FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4288458719> ?p ?o ?g. }

• W4288458719 endingPage "839" @default.
• W4288458719 startingPage "828" @default.
• W4288458719 abstract "The potential benefit of systemic therapy in patients with T1a HER2+ cancers is not well understood, and no consensus guidelines exist. We sought to investigate practice patterns of chemotherapy use in this population.From the National Cancer Database (2013-2018), we identified female patients with HER2+ cancers staged as cT1aN0 or pT1aN0 and stratified by receipt of chemotherapy. Using univariate and multivariable analyses we assessed the clinicopathologic features associated with the receipt of chemotherapy. We also compared rates of overall survival (OS).Of 5176 women with cT1aN0 HER2+ cancers, 88 (2%) received neoadjuvant chemotherapy. Younger age and hormone-receptor (HR) negative tumors were factors independently associated with receipt of neoadjuvant chemotherapy (all P < .001). Of 11,688 women with pT1aN0 HER2+ cancers, 5,588 (48%) received adjuvant chemotherapy. Rates of use increased over the analysis period from 39% in 2013 to 53% in 2018 (P < .001). Factors independently associated with receipt of adjuvant chemotherapy included younger age, having a poorly differentiated tumor, exhibiting lymphovascular invasion, undergoing adjuvant radiation (all P < .001). There were no differences in OS when comparing those who did and did not receive chemotherapy in either group.The use of chemotherapy in patients with HER2+ T1a cancers is increasing over time and is, as expected, more common among patients with unfavorable clinicopathologic features. Since no prognostic algorithm currently exists, more prospective data is needed to understand which of these patients may derive benefit from systemic therapy and which may safely avoid the morbidity of chemotherapy." @default.
• W4288458719 created "2022-07-29" @default.
• W4288458719 creator A5015270647 @default.
• W4288458719 creator A5021683582 @default.
• W4288458719 creator A5073657322 @default.
• W4288458719 creator A5078277564 @default.
• W4288458719 creator A5088151922 @default.
• W4288458719 creator A5091821771 @default.
• W4288458719 date "2022-12-01" @default.
• W4288458719 modified "2023-10-16" @default.
• W4288458719 title "Are We Overtreating Patients With T1a HER2+ Breast Cancer? An Analysis of the National Cancer Database." @default.
• W4288458719 cites W1035492860 @default.
• W4288458719 cites W1964641698 @default.
• W4288458719 cites W2068228843 @default.
• W4288458719 cites W2074643669 @default.
• W4288458719 cites W2086965131 @default.
• W4288458719 cites W2095861620 @default.
• W4288458719 cites W2096818458 @default.
• W4288458719 cites W2097541112 @default.
• W4288458719 cites W2106366706 @default.
• W4288458719 cites W2123591186 @default.
• W4288458719 cites W2140354367 @default.
• W4288458719 cites W2147415463 @default.
• W4288458719 cites W2149908785 @default.
• W4288458719 cites W2167955103 @default.
• W4288458719 cites W2461201386 @default.
• W4288458719 cites W2529908594 @default.
• W4288458719 cites W2565765808 @default.
• W4288458719 cites W2592783575 @default.
• W4288458719 cites W2624590002 @default.
• W4288458719 cites W2808460770 @default.
• W4288458719 cites W2902218997 @default.
• W4288458719 cites W2915047219 @default.
• W4288458719 cites W2928807055 @default.
• W4288458719 cites W2970780579 @default.
• W4288458719 cites W3031309839 @default.
• W4288458719 cites W3033657522 @default.
• W4288458719 cites W3118447990 @default.
• W4288458719 cites W3133758523 @default.
• W4288458719 cites W3165177412 @default.
• W4288458719 cites W4220725470 @default.
• W4288458719 doi "https://doi.org/10.1016/j.clbc.2022.07.013" @default.
• W4288458719 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36151019" @default.
• W4288458719 hasPublicationYear "2022" @default.
• W4288458719 type Work @default.
• W4288458719 citedByCount "1" @default.
• W4288458719 countsByYear W42884587192023 @default.
• W4288458719 crossrefType "journal-article" @default.
• W4288458719 hasAuthorship W4288458719A5015270647 @default.
• W4288458719 hasAuthorship W4288458719A5021683582 @default.
• W4288458719 hasAuthorship W4288458719A5073657322 @default.
• W4288458719 hasAuthorship W4288458719A5078277564 @default.
• W4288458719 hasAuthorship W4288458719A5088151922 @default.
• W4288458719 hasAuthorship W4288458719A5091821771 @default.
• W4288458719 hasConcept C121608353 @default.
• W4288458719 hasConcept C126322002 @default.
• W4288458719 hasConcept C143998085 @default.
• W4288458719 hasConcept C144301174 @default.
• W4288458719 hasConcept C2776694085 @default.
• W4288458719 hasConcept C2778740770 @default.
• W4288458719 hasConcept C2779013556 @default.
• W4288458719 hasConcept C2779786085 @default.
• W4288458719 hasConcept C2908647359 @default.
• W4288458719 hasConcept C38180746 @default.
• W4288458719 hasConcept C530470458 @default.
• W4288458719 hasConcept C71924100 @default.
• W4288458719 hasConcept C99454951 @default.
• W4288458719 hasConceptScore W4288458719C121608353 @default.
• W4288458719 hasConceptScore W4288458719C126322002 @default.
• W4288458719 hasConceptScore W4288458719C143998085 @default.
• W4288458719 hasConceptScore W4288458719C144301174 @default.
• W4288458719 hasConceptScore W4288458719C2776694085 @default.
• W4288458719 hasConceptScore W4288458719C2778740770 @default.
• W4288458719 hasConceptScore W4288458719C2779013556 @default.
• W4288458719 hasConceptScore W4288458719C2779786085 @default.
• W4288458719 hasConceptScore W4288458719C2908647359 @default.
• W4288458719 hasConceptScore W4288458719C38180746 @default.
• W4288458719 hasConceptScore W4288458719C530470458 @default.
• W4288458719 hasConceptScore W4288458719C71924100 @default.
• W4288458719 hasConceptScore W4288458719C99454951 @default.
• W4288458719 hasIssue "8" @default.
• W4288458719 hasLocation W42884587191 @default.
• W4288458719 hasLocation W42884587192 @default.
• W4288458719 hasOpenAccess W4288458719 @default.
• W4288458719 hasPrimaryLocation W42884587191 @default.
• W4288458719 hasRelatedWork W1810920307 @default.
• W4288458719 hasRelatedWork W2092771806 @default.
• W4288458719 hasRelatedWork W2143625559 @default.
• W4288458719 hasRelatedWork W2163267129 @default.
• W4288458719 hasRelatedWork W2361700749 @default.
• W4288458719 hasRelatedWork W2892287597 @default.
• W4288458719 hasRelatedWork W2969515167 @default.
• W4288458719 hasRelatedWork W2990288430 @default.
• W4288458719 hasRelatedWork W3160736738 @default.
• W4288458719 hasRelatedWork W4220765490 @default.
• W4288458719 hasVolume "22" @default.
• W4288458719 isParatext "false" @default.
• W4288458719 isRetracted "false" @default.

• next